BioPharmSignal logoBioPharmSignal

Biotech News

Progyny, Inc. Announces Third Quarter 2025 Results

Progyny (PGNY)ProgynyEarnings

Reports Revenue of $313.3 Million, Reflecting 9.3% Growth Raises Full Year Guidance to Reflect Continued Strength in Member Engagement Selling Season Yields Over 80 New Clients, 900,000 New Lives, and Near 100% Retention of Existing Base Record $156.0 Million in Operating Cash Flow Generated over

Related news

PGNYProgyny2026-08-06 20:01 EST

Progyny, Inc. Announces Second Quarter 2026 Results

PGNYProgyny2026-05-07 20:01 EST

Progyny, Inc. Announces First Quarter 2026 Results

FEMYFEMASYS2025-11-14 21:01 EST

Femasys Announces Third Quarter Financial Results for 2025

HSTMHealthStream2025-11-03 21:30 EST

HealthStream Announces Third Quarter 2025 Results

DAREDare Bioscience, Inc.2019-11-14 13:00 EST

Daré Bioscience Reports Third Quarter 2019 Financial Results and Provides Company Update

DAREDare Bioscience, Inc.2019-11-07 13:30 EST

Daré Bioscience to Host Third Quarter 2019 Financial Results and Company Update Conference Call and Webcast

COOThe Cooper Companies2026-07-30 20:15 EST

CooperCompanies Announces Release Date for Third Quarter 2026

SERASera Prognostics2026-03-18 20:05 EST

SERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS

TDOCTeladoc2026-02-25 21:05 EST

Teladoc Health Reports Fourth Quarter and Full Year 2025 Results

HSTMHealthStream2026-02-23 21:30 EST

HealthStream Announces Fourth Quarter & Full-Year 2025 Results

View all latest news

Progyny

Women's Health and Family Building Progyny manages employer-sponsored benefits for fertility, family building and women's health. Its programs are designed to guide members through complex care while helping benefit purchasers manage quality and cost. Integrated Benefit Platform The company's services include fertility treatment,...

Recent company news

PGNYProgyny2026-08-07 14:51 EST

Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference

PGNYProgyny2026-08-06 20:01 EST

Progyny, Inc. Announces Second Quarter 2026 Results

PGNYProgyny2026-07-23 19:30 EST

Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report

PGNYProgyny2026-05-28 13:04 EST

New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System

PGNYProgyny2026-05-26 12:00 EST

Progyny, Inc. Announces Share Repurchase Program

Stock data

Close
30.21 USD
Market cap
1.97B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States